Bukwang Pharmaceutical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bukwang Pharmaceutical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	31.5%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?

Nov 13

Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

May 22

Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Apr 03

Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Dec 19

Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

Nov 23

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bukwang Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A003000 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	138,927	-15,285	38,620	40,446	N/A
6/30/2024	116,583	-31,551	20,511	21,740	N/A
3/31/2024	123,087	-28,336	19,844	21,904	N/A
12/31/2023	125,928	-31,330	-11,929	-9,362	N/A
9/30/2023	162,391	-19,773	-2,790	2,761	N/A
6/30/2023	191,782	-4,355	-16,682	-10,771	N/A
3/31/2023	191,230	-5,259	-21,616	-16,311	N/A
12/31/2022	190,909	-2,475	11,471	16,461	N/A
9/30/2022	183,371	-1,326	-5,549	-3,723	N/A
6/30/2022	181,552	25	37,064	38,418	N/A
3/31/2022	182,548	179	34,632	35,469	N/A
12/31/2021	182,491	-917	25,735	26,525	N/A
9/30/2021	178,012	-4,380	16,673	17,650	N/A
6/30/2021	170,537	-11,194	1,702	2,964	N/A
3/31/2021	168,711	-9,475	19,535	21,223	N/A
12/31/2020	169,660	-7,203	-1,231	723	N/A
9/30/2020	171,579	140	-9,782	-8,318	N/A
6/30/2020	170,969	2,817	-14,075	-13,307	N/A
3/31/2020	170,116	-11,057	-34,077	-30,982	N/A
12/31/2019	168,194	-7,412	-28,313	-23,408	N/A
9/30/2019	158,981	-17,457	-22,148	-15,980	N/A
6/30/2019	195,507	129,926	-21,825	-14,396	N/A
3/31/2019	194,863	144,874	-8,327	-3,438	N/A
12/31/2018	194,224	145,670	3,090	6,817	N/A
9/30/2018	191,641	150,191	7,248	10,757	N/A
6/30/2018	153,731	9,501	N/A	7,459	N/A
3/31/2018	152,120	8,878	N/A	6,331	N/A
12/31/2017	150,743	11,091	N/A	8,563	N/A
9/30/2017	144,306	8,093	N/A	-176	N/A
6/30/2017	140,675	4,067	N/A	2,182	N/A
3/31/2017	139,578	6,664	N/A	-1,812	N/A
12/31/2016	138,618	15,807	N/A	-7,763	N/A
9/30/2016	143,162	22,757	N/A	-6,105	N/A
6/30/2016	144,390	33,640	N/A	-3,669	N/A
3/31/2016	141,975	33,891	N/A	1,095	N/A
12/31/2015	142,132	25,139	N/A	10,298	N/A
9/30/2015	139,543	25,356	N/A	18,317	N/A
6/30/2015	139,197	21,736	N/A	20,805	N/A
3/31/2015	138,956	22,783	N/A	23,255	N/A
12/31/2014	141,687	23,616	N/A	27,863	N/A
9/30/2014	139,681	22,981	N/A	32,747	N/A
6/30/2014	136,857	23,001	N/A	42,009	N/A
3/31/2014	133,484	22,331	N/A	N/A	N/A
12/31/2013	130,795	19,532	N/A	36,515	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A003000's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A003000's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A003000's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A003000's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A003000's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A003000's Return on Equity is forecast to be high in 3 years time

Bukwang Pharmaceutical Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?

New major risk - Financial data availability

Now 22% overvalued

Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.

H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.

Full year 2023 earnings released: ₩458 loss per share (vs ₩36.00 loss in FY 2022)

Second quarter 2023 earnings released: EPS: ₩7.00 (vs ₩6.00 loss in 2Q 2022)

Full year 2022 earnings released: ₩36.00 loss per share (vs ₩13.00 loss in FY 2021)

Upcoming dividend of ₩100.00 per share

Less than half of directors are independent

Bukwang Pharmaceutical Co., Ltd.(KOSE:A003000) dropped from KOSPI 200 Index

Less than half of directors are independent

Upcoming dividend of ₩90.91 per share

First quarter 2021 earnings released: ₩52.00 loss per share (vs ₩15.00 loss in 1Q 2020)

Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Full year 2020 earnings released: ₩115 loss per share (vs ₩114 loss in FY 2019)

Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Bukwang Pharmaceutical Co., Ltd., Annual General Meeting, Mar 19, 2021

New 90-day low: ₩21,050

Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

New 90-day high: ₩32,350

Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

New 90-day low: ₩23,000

New 90-day low: ₩26,700

New 90-day low: ₩32,850

New 90-day high - ₩41,550

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies